Y Mabs Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Y Mabs Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Y Mabs Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Y Mabs Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $964k | 141k | 6.82 |
| 2023-09-30 | $2.3M | 417k | 5.45 |
| 2023-06-30 | $260k | 38k | 6.79 |
| 2023-03-31 | $1.6M | 315k | 5.01 |
| 2022-12-31 | $4.7M | 965k | 4.88 |
| 2022-06-30 | $1.4M | 90k | 15.13 |
| 2022-03-31 | $2.5M | 207k | 11.90 |
| 2021-12-31 | $2.0M | 126k | 16.21 |
| 2021-09-30 | $3.3M | 116k | 28.50 |
| 2021-06-30 | $5.9M | 175k | 33.80 |
| 2021-03-31 | $2.8M | 91k | 30.24 |
| 2020-12-31 | $5.7M | 116k | 49.51 |
| 2020-09-30 | $332k | 9.2k | 36.23 |
| 2020-06-30 | $559k | 13k | 42.96 |
| 2020-03-31 | $990k | 38k | 26.11 |
| 2019-12-31 | $2.2M | 70k | 31.24 |